Table 2.
Results from Garshick et al. [3] without adjustment for duration of exposure, referred to as Garshick et al. [3] (modified)
| Exposure category | Average dose | Lower dose | Upper dose | RR | 95 % CI | Person years | Number of cases | |
|---|---|---|---|---|---|---|---|---|
| Lower | Upper | |||||||
| Reference | 15.5 | 0.0 | <30.9 | 1.00 | 1.00 | 1.00 | 105513 | 122 |
| Cat 1 | 51.3 | 30.9 | 71.7 | 1.18 | 0.92 | 1.52 | 104909 | 191 |
| Cat 2 | 111.0 | 71.7 | 150.3 | 1.17 | 0.88 | 1.55 | 102496 | 202 |
| Cat 3 | 250.5 | ≥150.3 | 1.19 | 0.86 | 1.63 | 87397 | 226 | |
Dose refers to the cumulative exposure to DEE in μg/m3-years. For every category (Reference, Cat 1, Cat 2, Cat 3), averages and the lower and upper limits of the dose are specified. Odds ratio OR with 95 % confidence intervals (95 % CI) and the number of person years and the number of observed lung cancer deaths per dose category are reported